Verve Therapeutics, Inc. (VERV) — Analyst estimates
Consensus analyst estimates for Verve Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 8.04M | -0.71 | 1 |
| 2027 | 15.00M | -1.9 | 5 |
| 2028 | 21.00M | -0.76 | 2 |
| 2029 | 9.00M | -3.94 | 1 |
Consensus analyst estimates by fiscal year.